| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.01 |